Literature DB >> 8589157

Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatment.

J Chang1, R Powles, J Mehta, N Paton, J Treleaven, B Jameson.   

Abstract

Cultures of blood and/or cerebrospinal fluid from four of 1,013 bone marrow transplant recipients treated at our center between January 1972 and April 1994 were positive for Listeria monocytogenes. The overall occurrence of listeriosis was 0.39 case per 100 transplantations. Allograft recipients had received prior treatment with parenteral methylprednisolone, thus supporting an association between listeriosis and corticosteroids. Treatment with parenteral ampicillin (200 mg/[kg.d]) and gentamicin is recommended for a minimum of 3 weeks before oral therapy. Two patients with penicillin allergies in this study failed to respond to chloramphenicol-based therapeutic regimens. Recurrent meningitis occurred in two patients, and the therapeutic use of intrathecal gentamicin/vancomycin did not confer a survival advantage (i.e., the patients did not survive).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589157     DOI: 10.1093/clinids/21.5.1289

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

Review 1.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 2.  Opportunistic infections of the central nervous system in the transplant patient.

Authors:  Bruce A Cohen; Valentina Stosor
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

3.  Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study.

Authors:  K E B van Veen; M C Brouwer; A van der Ende; D van de Beek
Journal:  Bone Marrow Transplant       Date:  2016-07-04       Impact factor: 5.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.